162 related articles for article (PubMed ID: 25786653)
21. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches.
Fiori J; Turroni S; Candela M; Gotti R
J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiota and the metabolic health of the host.
Joyce SA; Gahan CG
Curr Opin Gastroenterol; 2014 Mar; 30(2):120-7. PubMed ID: 24468803
[TBL] [Abstract][Full Text] [Related]
23. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis.
Nyangale EP; Mottram DS; Gibson GR
J Proteome Res; 2012 Dec; 11(12):5573-85. PubMed ID: 23116228
[TBL] [Abstract][Full Text] [Related]
24. Pilot dietary intervention with heat-stabilized rice bran modulates stool microbiota and metabolites in healthy adults.
Sheflin AM; Borresen EC; Wdowik MJ; Rao S; Brown RJ; Heuberger AL; Broeckling CD; Weir TL; Ryan EP
Nutrients; 2015 Feb; 7(2):1282-300. PubMed ID: 25690418
[TBL] [Abstract][Full Text] [Related]
25. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS/MS.
Kanemitsu Y; Mishima E; Maekawa M; Matsumoto Y; Saigusa D; Yamaguchi H; Ogura J; Tsukamoto H; Tomioka Y; Abe T; Mano N
Sci Rep; 2019 Dec; 9(1):19075. PubMed ID: 31836785
[TBL] [Abstract][Full Text] [Related]
27. Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats.
Lan A; Bruneau A; Philippe C; Rochet V; Rouault A; Hervé C; Roland N; Rabot S; Jan G
Br J Nutr; 2007 Apr; 97(4):714-24. PubMed ID: 17349084
[TBL] [Abstract][Full Text] [Related]
28. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes.
Claus SP; Tsang TM; Wang Y; Cloarec O; Skordi E; Martin FP; Rezzi S; Ross A; Kochhar S; Holmes E; Nicholson JK
Mol Syst Biol; 2008; 4():219. PubMed ID: 18854818
[TBL] [Abstract][Full Text] [Related]
29. Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMR.
de Graaf AA; Maathuis A; de Waard P; Deutz NE; Dijkema C; de Vos WM; Venema K
NMR Biomed; 2010 Jan; 23(1):2-12. PubMed ID: 19593762
[TBL] [Abstract][Full Text] [Related]
30. Metabolomics characterization of energy metabolism reveals glycogen accumulation in gut-microbiota-lacking mice.
Chuang HL; Huang YT; Chiu CC; Liao CD; Hsu FL; Huang CC; Hou CC
J Nutr Biochem; 2012 Jul; 23(7):752-8. PubMed ID: 21840188
[TBL] [Abstract][Full Text] [Related]
31. The role of the gut microbiota in metabolic health.
Janssen AW; Kersten S
FASEB J; 2015 Aug; 29(8):3111-23. PubMed ID: 25921831
[TBL] [Abstract][Full Text] [Related]
32. Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities.
Yen S; McDonald JA; Schroeter K; Oliphant K; Sokolenko S; Blondeel EJ; Allen-Vercoe E; Aucoin MG
J Proteome Res; 2015 Mar; 14(3):1472-82. PubMed ID: 25670064
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota-mediated drug interactions between lovastatin and antibiotics.
Yoo DH; Kim IS; Van Le TK; Jung IH; Yoo HH; Kim DH
Drug Metab Dispos; 2014 Sep; 42(9):1508-13. PubMed ID: 24947972
[TBL] [Abstract][Full Text] [Related]
34. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.
Islam KB; Fukiya S; Hagio M; Fujii N; Ishizuka S; Ooka T; Ogura Y; Hayashi T; Yokota A
Gastroenterology; 2011 Nov; 141(5):1773-81. PubMed ID: 21839040
[TBL] [Abstract][Full Text] [Related]
35. The footprints of gut microbial-mammalian co-metabolism.
Zheng X; Xie G; Zhao A; Zhao L; Yao C; Chiu NH; Zhou Z; Bao Y; Jia W; Nicholson JK; Jia W
J Proteome Res; 2011 Dec; 10(12):5512-22. PubMed ID: 21970572
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
37. Profiling the human intestinal environment under physiological conditions.
Shalon D; Culver RN; Grembi JA; Folz J; Treit PV; Shi H; Rosenberger FA; Dethlefsen L; Meng X; Yaffe E; Aranda-Díaz A; Geyer PE; Mueller-Reif JB; Spencer S; Patterson AD; Triadafilopoulos G; Holmes SP; Mann M; Fiehn O; Relman DA; Huang KC
Nature; 2023 May; 617(7961):581-591. PubMed ID: 37165188
[TBL] [Abstract][Full Text] [Related]
38. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse.
Yap IK; Li JV; Saric J; Martin FP; Davies H; Wang Y; Wilson ID; Nicholson JK; Utzinger J; Marchesi JR; Holmes E
J Proteome Res; 2008 Sep; 7(9):3718-28. PubMed ID: 18698804
[TBL] [Abstract][Full Text] [Related]
39. Pathways and functions of gut microbiota metabolism impacting host physiology.
Krishnan S; Alden N; Lee K
Curr Opin Biotechnol; 2015 Dec; 36():137-45. PubMed ID: 26340103
[TBL] [Abstract][Full Text] [Related]
40. Comparison of cellular fatty acid profiles of the microbiota in different gut regions of BALB/c and C57BL/6J mice.
Jussi V; Erkki E; Paavo T
Antonie Van Leeuwenhoek; 2005 Jul; 88(1):67-74. PubMed ID: 15928978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
